Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization.

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This is a randomized, controlled clinical trial with a two-sided superiority hypothesis. The study evaluates whether a 12-week pre-treatment with semaglutide prior to ovarian stimulation improves the number of good-quality blastocysts in overweight and obese women undergoing in vitro fertilization (IVF), compared to no pre-treatment.
Epistemonikos ID: 4fe3f42a558ceecd670df8562ed61e1450af94a7
First added on: Nov 22, 2025